Men's attitudes regarding genetic testing for hereditary prostate cancer risk.

OBJECTIVES Little is known about the attitudes of men unselected for a family history for prostate cancer concerning genetic testing for prostate cancer risk or genetic testing for inherited cancer predisposition. To explore this, we examined the interest in molecular testing for hereditary prostate cancer (HPC) predisposition among a self-selected cohort of 342 men presenting for prostate cancer screening. METHODS Participants were surveyed concerning their attitudes about DNA testing for HPC predisposition and knowledge of prostate cancer-associated risk factors, including heredity. RESULTS Of the participants completing the survey, 92% expressed interest in learning about DNA testing, and 89% stated that they would undergo DNA analysis for HPC predisposition, if available. Twenty-eight percent of respondents failed to demonstrate an adequate understanding of the concept of "inherited tendency." The demonstrated level of understanding of this concept did not differ by the respondent's family history, although it varied by race. An interest in learning about or undergoing testing did not vary by race, family history, or demonstrated understanding of the concept of inherited risk. CONCLUSIONS Among men presenting for routine prostate cancer screening, interest in learning about testing for HPC predisposition and in having such testing performed may be high. The data also provide evidence that, in a population of men unselected for family history, interest in molecular testing for this common, male-specific cancer may parallel the high interest level demonstrated among women in DNA testing for inherited breast and ovarian cancer risk.

[1]  F. Collins,et al.  Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus , 1997 .

[2]  M. Sheridan Letter: The handicapped family. , 1975 .

[3]  M. Andrykowski,et al.  Interest in learning of personal genetic risk for cancer: a general population survey. , 1996, Preventive medicine.

[4]  J. Benkendorf,et al.  Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. , 1997, Journal of the National Cancer Institute.

[5]  A. Whittemore,et al.  Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. , 1997, Journal of the National Cancer Institute.

[6]  B. Rimer,et al.  Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. , 1997, American journal of medical genetics.

[7]  D. Berry,et al.  Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  W J Hall,et al.  Women's receptivity to testing for a genetic susceptibility to breast cancer. , 1995, American journal of public health.

[9]  T. Beaty,et al.  Hereditary prostate cancer: epidemiologic and clinical features. , 1993, The Journal of urology.

[10]  O. Bratt Hereditary prostate cancer , 2000, BJU international.

[11]  Kenneth Offit,et al.  Decision-Making About Genetic Testing Among Women at Familial Risk for Breast Cancer , 1997, Psychosomatic medicine.

[12]  C. Isaacs,et al.  Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. , 1997, Patient education and counseling.

[13]  C. Lerman,et al.  Interest in genetic testing among first-degree relatives of breast cancer patients. , 1995, American journal of medical genetics.

[14]  E. Goode,et al.  Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. , 1999, American journal of human genetics.

[15]  H. Olsson,et al.  Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing. , 1997, Urology.

[16]  G. Murphy,et al.  American Cancer Society guidelines for the early detection of prostate cancer , 1997, Cancer.

[17]  J. Oesterling,et al.  Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. , 1997, Journal of the National Cancer Institute.

[18]  F. Collins,et al.  Evidence for a prostate cancer susceptibility locus on the X chromosome. , 1998, Nature Genetics.

[19]  N. Holtzman,et al.  Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. , 1994, American journal of human genetics.

[20]  A. Gomez‐Caminero,et al.  Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers , 1996, International journal of cancer.

[21]  W. Vogel,et al.  Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. , 1998, American journal of human genetics.

[22]  J. Benkendorf,et al.  Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  C. Mathew,et al.  Uptake of cystic fibrosis testing in primary care: supply push or demand pull? , 1993, BMJ.

[24]  G. E. Smith,et al.  African-American males and prostate cancer: assessing knowledge levels in the community. , 1997, Journal of the National Medical Association.

[25]  D A Meyers,et al.  Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.

[26]  S. Loader,et al.  Genetic testing for breast-ovarian cancer susceptibility: a regional trial. , 1998, Genetic testing.

[27]  D. Craufurd,et al.  UPTAKE OF PRESYMPTOMATIC PREDICTIVE TESTING FOR HUNTINGTON'S DISEASE , 1989, The Lancet.

[28]  B. Trock,et al.  BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.

[29]  J. Carpten,et al.  In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer. , 1999, American journal of human genetics.

[30]  R. Croyle,et al.  Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. , 1993, Preventive medicine.

[31]  M. Morris,et al.  Reluctance to undergo predictive testing: the case of Huntington disease. , 1993, American journal of medical genetics.

[32]  D. Bowen,et al.  Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  J. Struewing,et al.  Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[34]  T. Beaty,et al.  Mendelian inheritance of familial prostate cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  T H Beaty,et al.  Risk of cancer in relatives of prostate cancer probands. , 1995, Journal of the National Cancer Institute.

[36]  G. Murphy,et al.  American Cancer Society guideline for the early detection of prostate cancer: Update 1997 , 1997, CA: a cancer journal for clinicians.

[37]  M. Daly,et al.  Attitudes about genetic testing for breast-ovarian cancer susceptibility. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  J. Horm,et al.  Current status of prostate cancer in North American black males. , 1990, Journal of the National Medical Association.

[39]  M. Cowen,et al.  A national survey of attitudes regarding participation in prostate carcinoma testing , 1996, Cancer.